Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Chowdhury

Showing results (31-40 of 151) with videos related to

Pageof 16
Sort By:
Hematology/Oncology Clinics of North America|July 19, 2011
Systemic therapy for metastatic non-clear-cell renal cell carcinoma: recent progress and future directionsSimon Chowdhury, Marc R Matrana, Christopher Tsang, et al.
BMJ Open|July 14, 2016
Prostate-specific antigen testing in inner London general practices: are those at higher risk most likely to get tested?Paul Nderitu, Mieke Van Hemelrijck, Mark Ashworth, et al.
Journal of Virology|January 29, 2003
Targeted retroviral infection of tumor cells by receptor cooperationFrancisco Martin, Simon Chowdhury, Stuart J Neil, et al.
BMC Cancer|September 27, 2014
Obesity and cancer: the role of vitamin DThurkaa Shanmugalingam, Danielle Crawley, Cecilia Bosco, et al.
Cancers|November 12, 2013
Clinical investigation of the role of interleukin-4 and interleukin-13 in the evolution of prostate cancerRobert Goldstein, Charles Hanley, Jonathan Morris, et al.
BMC Cancer|December 21, 2014
Serum glucose and risk of cancer: a meta-analysisDanielle J Crawley, Lars Holmberg, Jennifer C Melvin, et al.
Cancer Management and Research|February 25, 2022
Guidelines for Management of Treatment-Emergent Adverse Events During Rucaparib Treatment of Patients with Metastatic Castration-Resistant Prostate CancerBrian W Labadie, David S Morris, Alan H Bryce, et al.
Cancer|March 27, 2014
Brain metastases associated with germ cell tumors may be treated with chemotherapy aloneAnna Hardt, Jonathan Krell, Peter D Wilson, et al.
Advances in Therapy|November 19, 2021
Apalutamide Compared with Darolutamide for the Treatment of Non-metastatic Castration-Resistant Prostate Cancer: Efficacy and Tolerability in a Matching-Adjusted Indirect ComparisonSimon Chowdhury, Stephane Oudard, Hiroji Uemura, et al.
Asia-Pacific Journal of Clinical Oncology|April 19, 2024
A practical guide for the use of apalutamide for non-metastatic castration-resistant prostate cancer in AustraliaGavin Marx, Simon Chowdhury, Laurence Krieger, et al.
Pageof 16

Showing results (31-40 of 151) with videos related to

Sort By:
Pageof 16
Hematology/Oncology Clinics of North America|July 19, 2011
Systemic therapy for metastatic non-clear-cell renal cell carcinoma: recent progress and future directionsSimon Chowdhury, Marc R Matrana, Christopher Tsang, et al.
BMJ Open|July 14, 2016
Prostate-specific antigen testing in inner London general practices: are those at higher risk most likely to get tested?Paul Nderitu, Mieke Van Hemelrijck, Mark Ashworth, et al.
Journal of Virology|January 29, 2003
Targeted retroviral infection of tumor cells by receptor cooperationFrancisco Martin, Simon Chowdhury, Stuart J Neil, et al.
BMC Cancer|September 27, 2014
Obesity and cancer: the role of vitamin DThurkaa Shanmugalingam, Danielle Crawley, Cecilia Bosco, et al.
Cancers|November 12, 2013
Clinical investigation of the role of interleukin-4 and interleukin-13 in the evolution of prostate cancerRobert Goldstein, Charles Hanley, Jonathan Morris, et al.
BMC Cancer|December 21, 2014
Serum glucose and risk of cancer: a meta-analysisDanielle J Crawley, Lars Holmberg, Jennifer C Melvin, et al.
Cancer Management and Research|February 25, 2022
Guidelines for Management of Treatment-Emergent Adverse Events During Rucaparib Treatment of Patients with Metastatic Castration-Resistant Prostate CancerBrian W Labadie, David S Morris, Alan H Bryce, et al.
Cancer|March 27, 2014
Brain metastases associated with germ cell tumors may be treated with chemotherapy aloneAnna Hardt, Jonathan Krell, Peter D Wilson, et al.
Advances in Therapy|November 19, 2021
Apalutamide Compared with Darolutamide for the Treatment of Non-metastatic Castration-Resistant Prostate Cancer: Efficacy and Tolerability in a Matching-Adjusted Indirect ComparisonSimon Chowdhury, Stephane Oudard, Hiroji Uemura, et al.
Asia-Pacific Journal of Clinical Oncology|April 19, 2024
A practical guide for the use of apalutamide for non-metastatic castration-resistant prostate cancer in AustraliaGavin Marx, Simon Chowdhury, Laurence Krieger, et al.
Pageof 16